Related Experiment Videos
Thymopentin in chronic Trichophyton rubrum infection
Survey of Immunologic Research
|January 1, 1985
Summary
Thymopentin effectively treated chronic Trichophyton rubrum infections in two patients who failed other therapies. This immunomodulator demonstrated sustained remission, suggesting a role in enhancing cellular immunity for fungal infections.
Area of Science:
- Dermatology
- Immunology
- Mycology
Background:
- Chronic Trichophyton rubrum infections pose treatment challenges.
- Griseofulvin and topical treatments were ineffective or caused adverse reactions in these patients.
- Impaired cellular immunity is suspected in chronic dermatophyte infections.
Observation:
- Two patients with chronic T. rubrum infections were treated with thymopentin.
- Thymopentin was administered subcutaneously at 50 mg three times weekly for six weeks.
- Clinical improvement was observed within three weeks, with near-complete remission following.
Findings:
- Thymopentin induced rapid clinical improvement and remission in chronic T. rubrum infections.
- The therapeutic benefits persisted for up to seven months post-treatment.
- Re-administration of thymopentin elicited a similar positive response pattern.
Implications:
- Thymopentin may be a viable therapeutic option for recalcitrant T. rubrum infections.
- The drug's efficacy suggests it enhances cellular immunity, addressing a potential underlying immune defect.
- Further research into thymopentin's immunomodulatory effects in fungal infections is warranted.